BNIP3 is degraded by ULK1-dependent autophagy via MTORC1 and AMPK

Autophagy

Volumn 9, Issue 3, 2013, Pages 345-360

  Park, Chang Wook ^a   Hong, Sun Mi ^a   Kim, Eung Sam ^a   Kwon, Jung Hee ^b   Kim, Kyong Tai ^a   Nam, Hong Gil ^c   Choi, Kwan Yong ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b CbsBioscience Inc   (South Korea)

^c Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

Author keywords

AMPK; Autophagy; BECN1; BNIP3; Hypoxia; MTOR; Torin1; ULK1

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MICROTUBULE ASSOCIATED PROTEIN 1; PHOSPHOTRANSFERASE; PROTEASOME; PROTEIN BNIP3; UNC 51 LIKE KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; KWASHIORKOR; MACROAUTOPHAGY; MITOCHONDRION; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STARVATION;

EID: 84877333139     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.23072     Document Type: Article

References (52)

1. Høyer-Hansen M, Jäättelä M. Autophagy: An emerging target for cancer therapy. Autophagy 2008; 4:574-80; PMID:18362515
2. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008; 8:705-13; PMID:19143055; http://dx.doi.org/10.1038/nrc2468.
3. Mazure NM, Pouysségur J. Hypoxia-induced autophagy: Cell death or cell survival? Curr Opin Cell Biol 2010; 22:177-80; PMID:20022734; http://dx.doi.org/10.1016/j.ceb.2009.11.015
4. Yorimitsu T, Klionsky DJ. Autophagy: Molecular machinery for self-eating. Cell Death Differ 2005; 12(Suppl 2):1542-52; PMID:16247502; http://dx.doi.org/10.1038/sj.cdd.4401765
5. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 2010; 22:132-9; PMID:20056399; http://dx.doi.org/10.1016/j. ceb.2009.12.004
6. Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb2152
7. Kundu M. ULK1, mammalian target of rapamycin, and mitochondria: Linking nutrient availability and autophagy. Antioxid Redox Signal 2011; 14:1953-8; PMID:21235397; http://dx.doi.org/10.1089/ars.2010.3809
8. Roach PJ. AMPK-> ULK1-> autophagy. Mol Cell Biol 2011; 31:3082-4; PMID:21628530; http://dx.doi.org/10.1128/MCB.05565-11
9. Rabinowitz JD, White E. Autophagy and metabolism. Science 2010; 330:1344-8; PMID:21127245; http://dx.doi.org/10.1126/science.1193497
10. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994; 79:341-51; PMID:7954800; http://dx.doi.org/10. 1016/0092-8674(94)90202-X
11. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, et al. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 2000; 275:1439-48; PMID:10625696; http://dx.doi.org/10.1074/jbc.275. 2.1439
12. Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, Rozenknop A, et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 2010; 11:45-51; PMID:20010802; http://dx.doi.org/10.1038/embor.2009.256
13. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000; 97:9082-7; http://dx.doi.org/10.1073/pnas.97.16.9082
14. Chinnadurai G, Vijayalingam S, Gibson SB. BNIP3 subfamily BH3-only proteins: Mitochondrial stress sensors in normal and pathological functions. Oncogene 2008; 27(Suppl 1):S114-27; PMID:19641497; http://dx.doi.org/10.1038/ onc.2009.49
15. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouysségur J, et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29:2570-81; PMID:19273585; http://dx.doi.org/10.1128/MCB.00166-09
16. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA, et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2007; 14:146-57; PMID:16645637; http://dx.doi.org/10.1038/sj.cdd.4401936
17. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005; 24:980-91; PMID:15592527; http://dx.doi.org/10.1038/sj.onc.1208095
18. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008; 283:10892-903; PMID:18281291; http://dx.doi.org/10. 1074/jbc. M800102200
19. Gustafsson AB. Bnip3 as a dual regulator of mitochondrial turnover and cell death in the myocardium. Pediatr Cardiol 2011; 32:267-74; PMID:21210091; http://dx.doi.org/10.1007/s00246-010-9876-5
20. Rikka S, Quinsay MN, Thomas RL, Kubli DA, Zhang X, Murphy AN, et al. Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ 2011; 18:721-31; PMID:21278801; http://dx.doi.org/10.1038/ cdd.2010.146
21. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4:891-9; PMID:15516961; http://dx.doi.org/10.1038/nrc1478
22. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271:32529-37; PMID:8955077; http://dx.doi.org/10.1074/jbc.271.51.32529
23. Cuervo AM. Cell biology. Autophagy's top chef. Science 2011; 332:1392-3; PMID:21680833; http://dx.doi.org/10.1126/science.1208607
24. Kundu M, Thompson CB. Macroautophagy versus mitochondrial autophagy: A question of fate? Cell Death Differ 2005; 12(Suppl 2):1484-9; PMID:16247496; http://dx.doi.org/10.1038/sj.cdd.4401780
25. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313-26; PMID:20144757; http://dx.doi.org/10.1016/j. cell.2010.01.028
26. He H, Dang Y, Dai F, Guo Z, Wu J, She X, et al. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem 2003; 278:29278-87; PMID:12740394; http://dx.doi.org/10.1074/jbc.M303800200
27. Yasuda M, Theodorakis P, Subramanian T, Chinnadurai G. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem 1998; 273:12415-21; PMID:9575197; http://dx.doi.org/10.1074/jbc.273.20.12415
28. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A 2002; 99:12825-30; PMID:12226479; http://dx.doi.org/10.1073/ pnas.202474099
29. Gang H, Hai Y, Dhingra R, Gordon JW, Yurkova N, Aviv Y, et al. A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes. Circ Res 2011; 108:1084-92; PMID:21415393; http://dx.doi.org/10.1161/CIRCRESAHA.110.238709
30. Billen LP, Shamas-Din A, Andrews DW. Bid: A Baxlike BH3 protein. Oncogene 2008; 27(Suppl 1):S93-104; PMID:19641510; http://dx.doi.org/10.1038/onc.2009.47
31. Danial NN. BAD: Undertaker by night, candyman by day. Oncogene 2008; 27(Suppl 1):S53-70; PMID:19641507; http://dx.doi.org/10.1038/onc.2009.44
32. Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: An overview. Oncogene 2008; 27(Suppl 1):S2-19; PMID:19641503; http://dx.doi.org/10.1038/onc.2009.39
33. Sakamaki J, Daitoku H, Ueno K, Hagiwara A, Yamagata K, Fukamizu A. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt. Proc Natl Acad Sci U S A 2011; 108:6085-90; PMID:21444773; http://dx.doi.org/10.1073/pnas.1015328108
34. Ma X, Godar RJ, Liu H, Diwan A. Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte death. Autophagy 2012; 8:297-309; PMID:22302006; http://dx.doi.org/10.4161/auto.18658
35. Hanna RA, Quinsay MN, Orogo AM, Giang K, Rikka S, Gustafsson ÅB. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 2012; 287:19094-104; PMID:22505714; http://dx.doi.org/10. 1074/jbc.M111.322933
36. Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7:279-96; PMID:21189453; http://dx.doi.org/10.4161/ auto.7.3.14487
37. Guertin DA, Sabatini DM. The pharmacology of mTOR inhibition. Sci Signal 2009; 2:pe24; PMID:19383975; http://dx.doi.org/10.1126/scisignal.267pe24
38. Thoreen CC, Sabatini DM. Rapamycin inhibits mTORC1, but not completely. Autophagy 2009; 5:725-6; PMID:19395872; http://dx.doi.org/10.4161/auto.5.5.8504
39. Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012; 32:2-11; PMID:22025673; http://dx.doi.org/10.1128/MCB.06159-11
40. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331:456-61; PMID:21205641; http://dx.doi.org/10.1126/science. 1196371
41. Rothbart SB, Racanelli AC, Moran RG. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas. Cancer Res 2010; 70:10299-309; PMID:21159649; http://dx.doi.org/10.1158/0008-5472.CAN-10-1873
42. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007; 27:6229-42; PMID:17576813; http://dx.doi.org/10.1128/MCB.02246-06
43. Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003; 22:4734-44; PMID:12879018; http://dx.doi.org/10.1038/sj.onc.1206666
44. Codogno P, Mehrpour M, Proikas-Cezanne T. Canonical and non-canonical autophagy: Variations on a common theme of self-eating? Nat Rev Mol Cell Biol 2012; 13:7-12; PMID:22166994; http://dx.doi.org/10.1038/nrm3249
45. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008; 8:851-64; PMID:18846101; http://dx.doi.org/10.1038/nrc2501
46. Papandreou I, Lim AL, Laderoute K, Denko NC. Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ 2008; 15:1572-81; PMID:18551130; http://dx.doi.org/10.1038/cdd. 2008.84
47. Kaper F, Dornhoefer N, Giaccia AJ. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions. Cancer Res 2006; 66:1561-9; PMID:16452213; http://dx.doi.org/10.1158/0008-5472.CAN-05-3375
48. Chhipa RR, Wu Y, Ip C. AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia. Cell Signal 2011; 23:1466-72; PMID:21554950; http://dx.doi.org/10.1016/ j.cellsig. 2011.04.008
49. Willis SN, Adams JM. Life in the balance: How BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005; 17:617-25; PMID:16243507; http://dx.doi.org/10.1016/j.ceb.2005.10.001
50. Cosse J-P, Rommelaere G, Ninane N, Arnould T, Michiels C. BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway. Biochem Pharmacol 2010; 80:1160-9; PMID:20637734; http://dx.doi.org/10.1016/j.bcp.2010.07.009
51. Khan S, Salloum F, Das A, Xi L, Vetrovec GW, Kukreja RC. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol 2006; 41:256-64; PMID:16769083; http://dx.doi.org/10.1016/j.yjmcc.2006.04.014
52. Ding Y, Sun X, Redfield M, Kushwaha S, Xu X. Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics. Cell Cycle 2012; 11:428-9; PMID:22262179; http://dx.doi.org/10.4161/cc.11.3. 19164